Shooting for $5B in sales, India’s Lupin says it can actually hit U.S. launch goal this year

EJ Lane

SINGAPORE–Despite missing its target for bringing 15 to 20 drugs to the market last , is optimistic enough about 2015 that it seeks possible acquisitions in Russia to expand its presence there.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS